Sofia AMARAL-GARCIA, I3h Institute, ULB

Robert BAROUKI, INSERM et Université de Paris

Tamas BERECZKY, EUPATI organization

Cédric BLANPAIN, Laboratory of Stem Cells and Cancer, ULB

Giovanni BRIGANTI, Lecturer in Medical Technology, ULB

Daniela COUTO, Biogeneration Ventures, DC Naarden

Nathalie DELZENNE, Louvain Drug Research Institute, UCLouvain

Mathias DEWATRIPONT, I3h Institute & Solvay Brussels School, ULB

Lode DEWULF, Servier

Anne-Laure DRENO, AstraZeneca, Brussels

Hans-Georg EICHLER, European Medicines Agency

Bruno FLAMION, Namur Research Institute for Life Sciences, UNamur

Michel GOLDMAN, I3h Institute, ULB

Emmanuel HANON, GSK, Wavre

Mike HARDMAN, Faculty of Pharmaceutical Medicine, UK

Isabelle HUYS, Pharmaceutical and Pharmacological Sciences, KULeuven

Dipak KALRA, University College of London

Michel KAZATCHKINE, UN Special Envoy for HIV/AIDS

Ingrid KLINGMANN, Pharmatrain Federation

Patrick LEGROS, I3h Institute & Solvay Brussels School, ULB

Frank LUYTEN, Skeletal Biology and Engineering Research Center, KULeuven)

Azèle MATHIEU, LifeTech.Brussels

Mattias NEYT, Belgian Health Care Knowledge Centre, KCE

Hilde STEVENS, I3h Institute, ULB

Ellen t’HOEN, University Medical Centre of Groningen

Pedro OLIVEIRA, Copenhagen Business School

Peter PIOT and Heidi LARSON, London School of Hygiene and Tropical Medicine

Pierre VAN DAMME, Vaccine and Infectious Disease Institute, University of Antwerp

Bruno VAN POTTELSBERGHE, Solvay Brussels School, ULB